Literature DB >> 7610463

Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels.

Y Kawashima1, H Kobayashi, H Miura, H Kozuka.   

Abstract

Male rats were fed a diet that contained perfluorooctanoic acid (PFOA) and perfluorodecanoic acid (PFDA) at concentrations ranging from 0.0025-0.04% (w/w) and from 0.00125-0.01% (w/w), respectively, for 1 week. The hepatic responses of the rats to PFOA and PFDA were examined. Upon the administration of PFOA and PFDA, three peroxisome proliferator-responsive parameters, peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine (1-acyl-GPC) acyltransferase and cytosolic long-chain acyl-CoA hydrolase, were induced in a dose-dependent manner. A multiple regression analysis of the three parameters revealed that the data from rats treated with PFOA and PFDA shared one common line, indicating a marked correlation among the inductions of the three parameters. The activities of glutathione (GSH) S-transferases towards 1-chloro-2,4-dinitrobenzene (CDNB) and 1,2-dichloro-4-nitrobenzene (DCNB) were depressed by PFOA and PFDA. Significant inverse correlations were found between activities of GSH S-transferases and peroxisomal beta-oxidation. The administration of PFOA and PFDA significantly increased hepatic concentration of triacylglycerol. The perfluorocarboxylic acids at relatively high doses caused accumulation of cholesterol in liver. Electron microscopic studies showed that the administration of PFOA and PFDA caused an increase in cell size and proliferations of peroxisomes, and that the treatment of rats with PFDA at dietary concentration of 0.01% caused a marked increase in small lipid droplet in hepatocytes, indicative of hepatotoxic manifestations. The present results suggest that when PFOA and PFDA are administered at low levels, there are no differences between the properties of the perfluorocarboxylic acids as peroxisome proliferators, although the administration of PFDA at the doses exceeding a certain level becomes markedly toxic to hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7610463     DOI: 10.1016/0300-483x(95)03027-d

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  5 in total

1.  Perfluorodecanoic acid enhances the formation of oleic acid in rat liver.

Authors:  A Yamamoto; Y Kawashima
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

2.  Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor.

Authors:  Manhai Long; Mandana Ghisari; Eva Cecilie Bonefeld-Jørgensen
Journal:  Environ Sci Pollut Res Int       Date:  2013-03-29       Impact factor: 4.223

3.  Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat.

Authors:  Rachel Rogers Worley; Jeffrey Fisher
Journal:  Toxicol Appl Pharmacol       Date:  2015-11-06       Impact factor: 4.219

Review 4.  Nano-Sized Cyclodextrin-Based Molecularly Imprinted Polymer Adsorbents for Perfluorinated Compounds-A Mini-Review.

Authors:  Abdalla H Karoyo; Lee D Wilson
Journal:  Nanomaterials (Basel)       Date:  2015-06-04       Impact factor: 5.076

5.  Perfluorodecanoic acid (PFDA) promotes gastric cell proliferation via sPLA2-IIA.

Authors:  Tianyi Dong; Yanping Peng; Ning Zhong; Fengyan Liu; Hanyu Zhang; Mengchen Xu; Rutao Liu; Mingyong Han; Xingsong Tian; Jihui Jia; Lap Kam Chang; Liang-Hong Guo; Shili Liu
Journal:  Oncotarget       Date:  2017-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.